Home / Business and Economy / Rooney's Investment Soars as Protein Firm Surges
Rooney's Investment Soars as Protein Firm Surges
18 Feb
Summary
- Applied Nutrition sales rose 57% to £47.6 million.
- Company expects full-year performance to exceed forecasts.
- Coleen Rooney recently doubled her investment in the firm.
Coleen Rooney has experienced a substantial increase in the value of her stake in Applied Nutrition, a protein powder and supplement company. The firm's stock price has climbed significantly following an optimistic trading update.
During the six months concluding in January, Applied Nutrition's sales experienced a remarkable surge of 57%, reaching £47.6 million. Earnings for this period also surpassed the expectations of the company's management.
The FTSE 250 listed group, which had its initial public offering in 2024 for £350 million, has projected that its financial performance for the entire year ending July will outperform current City forecasts. These predictions anticipate earnings of £37.7 million on sales of £133.5 million.
In reaction to the upbeat news, shares of Applied Nutrition saw a 6.2% increase, adding 15p to trade at 256.5p. This performance places the stock close to its record high of 259.5p reached last month, a significant rise from its initial listing price of 140p. This rally provides a considerable boost to media personality Coleen Rooney, who notably doubled her investment in the company just last week.
